KRAS and lung carcinoma: In a model of KRAS-driven lung cancer, HK2 is transcriptionally activated by the transcription factor BACH1, which is stabilized by antioxidant treatment, triggering metastatic spread favored by glycolytic metabolism in cancer cells [23].